Stock Market Reviews

ABCL (AbCellera Biologics Inc.) News

Get the latest news, insights, and market updates on ABCL (AbCellera Biologics Inc.). Explore the news page 3 on MyTopStock.com for investor discussions, analysis, and real-time stock performance coverage.

• TD Cowen Reiterates Buy Rating on ABCL After AbCellera Biologics Dosed First Participants of ABCL575
  AbCellera Biologics Inc. (NASDAQ:ABCL) is one of the 12 Best NASDAQ Penny Stocks to Buy According to Hedge Funds. On September 11, TD Cowen reiterated its Buy rating on AbCellera Biologics Inc. (NASDAQ:ABCL), without giving a price target. TD Cowen analyst Brendan Smith sees the company’s focus on expanding its internal pipeline and strengthening its […]
  Sep 15, 2025 - $ABCL
• 3 Promising Penny Stocks With Market Caps Under $2B
  As the United States stock market reaches record highs, investors are keenly watching for opportunities that align with the current economic landscape. Amid expectations of potential interest rate cuts, some investors are turning their attention to penny stocks—an investment area that, despite its outdated moniker, remains relevant today. These smaller or newer companies can offer unique value propositions and growth potential when backed by strong financials. In this article, we will explore...
  Sep 10, 2025 - $ABCL
• AbCellera Appoints Dr. Sarah Noonberg as Chief Medical Officer
  VANCOUVER, British Columbia, September 10, 2025--AbCellera Appoints Dr. Sarah Noonberg as Chief Medical Officer
  Sep 10, 2025 - $ABCL
• Bullish AbCellera Biologics Insiders Loaded Up On US$940.3k Of Stock
  In the last year, multiple insiders have substantially increased their holdings of AbCellera Biologics Inc...
  Sep 8, 2025 - $ABCL
• AbCellera Biologics Inc. (ABCL) Launches First Human Trial for Menopause Therapy
  We recently published 10 Best Biotech Stocks to Buy Under $10. AbCellera Biologics Inc. is placed ninth among them. AbCellera Biologics Inc. (NASDAQ:ABCL) is a Canadian biotechnology company using its antibody discovery platform to develop therapies for cancer, autoimmune, metabolic, and endocrine disorders. Long recognized for industry partnerships, the company is now advancing into clinical […]
  Aug 28, 2025 - $ABCL
• AbCellera Doses First Participants in a Phase 1 Clinical Trial of ABCL575
  VANCOUVER, British Columbia, August 27, 2025--AbCellera Doses First Participants in a Phase 1 Clinical Trial of ABCL575
  Aug 27, 2025 - $ABCL
• Truist Financial Reiterates a Buy Rating on AbCellera Biologics (ABCL), Sets a $10 PT
  AbCellera Biologics Inc. (NASDAQ:ABCL) is one of the top strong buy stocks under $5 to buy now. In a report released on August 14, Srikripa Devarakonda from Truist Financial reiterated a Buy rating on AbCellera Biologics Inc. (NASDAQ:ABCL), setting a price target of $10.00. AbCellera Biologics Inc. (NASDAQ:ABCL) reported its fiscal Q2 results on August […]
  Aug 26, 2025 - $ABCL
• AbCellera Biologics (ABCL) Advances Proprietary Pipeline with Promising Phase 1 Trial Results
  We recently published 12 Best Healthcare Stocks to Buy Under $30. AbCellera Biologics Inc. (NASDAQ:ABCL) is one of the best healthcare stocks. AbCellera Biologics Inc. (NASDAQ:ABCL) is a biotech company specializing in discovering and developing therapeutic antibodies across various disease areas, including cancer, metabolic, endocrine, and autoimmune disorders. Their integrated platform combines technology, data science, […]
  Aug 17, 2025 - $ABCL